Device Therapies: New Indications and Future Directions

Author(s): Prabhat Kumar, Jennifer D. Schwartz.

Journal Name: Current Cardiology Reviews

Volume 11 , Issue 1 , 2015

Submit Manuscript
Submit Proposal

Graphical Abstract:


Implantable cardioverter-defibrillator (ICDs), cardiac resynchronization (CRT) and combination (CRT-D) therapy have become an integral part of the management of patients with heart failure with reduced ejection fraction (HFrEF). ICDs treat ventricular arrhythmia and CRTs improve left ventricular systolic function by resynchronizing ventricular contraction. Device therapies (ICD, CRT-D), have been shown to reduce all-cause mortality, including sudden cardiac death. Hospitalizations are reduced with CRT and CRT-D therapy. Major device related complications include device infection, inappropriate shocks, lead malfunction and complications related to extraction of devices. Improvements in device design and implantation have included progressive miniaturization and increasing battery life of the device, optimization of response to CRT, and minimizing inappropriate device therapy. Additionally, better definition of the population with the greatest benefit is an area of active research.

Keywords: Cardiac implantable electronic device, cardiac resynchronization therapy (CRT), heart failure (HF), implantable cardioverter-defibrillator (ICD), primary prevention, secondary prevention, sudden cardiac death (SCD).

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [33 - 41]
Pages: 9
DOI: 10.2174/1573403X1101141106121553

Article Metrics

PDF: 38